Novus Therapeutics, Inc.

Home » Novus Therapeutics, Inc.

Secondary

Novus Therapeutics, Inc.

Secondary offering. Novus Therapeutics, Inc. (“Novus”) is a specialty pharmaceutical company focused on developing products for disorders of the ear, nose, and throat (“ENT”).

Symbol

NVUS

Last Closing Price
$5.42

Shares
TBD

Anticipated Date
TBD

Underwriters
Piper Jaffray

To view the prospectus for Novus Therapeutics, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253